Differences and Predictive Value for Clinical Staging of Preoperative NLR and PLR in Gastric Cancer Patients

1. Abstract

1.1. Context: Gastric Cancer (GC) is one of the most prevalent types of malignancies, and its mortality rate ranks third among malignant tumors. The treatment of gastric cancer is mainly divided into surgical treatment, chemotherapy and radiotherapy, etc. Clinically, stage I, II and III tumors are radical resectable tumors and surgical treatment is the first choice, while stage IV tumors are non-radical resectable tumors and non-surgical treatment should be considered first.